— Know what they know.
Not Investment Advice

ARVN NASDAQ

Arvinas, Inc.
1W: -3.4% 1M: -14.4% 3M: -24.1% YTD: -20.7% 1Y: +37.0% 3Y: -61.0% 5Y: -86.4%
$9.09
-0.01 (-0.11%)
 
Weekly Expected Move ±6.0%
$8 $9 $9 $10 $10
NASDAQ · Healthcare · Biotechnology · Alpha Radar Strong Sell · Power 29 · $586.5M mcap · 56M float · 1.65% daily turnover · Short 38% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
36.7 / 100
NoneWeakNarrowWide
Primary source: Intangible Assets  ·  ROIC: 81.2%
Cost Advantage
42
Intangibles
59
Switching Cost
12
Network Effect
43
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ARVN has No discernible competitive edge (36.7/100). The business operates without significant structural advantages. The primary source of advantage is Intangible Assets. ROIC of 81.2% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$18
Low
$19
Avg Target
$20
High
Based on 2 analysts since May 12, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 20Hold: 5Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$14.75
Analysts4
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-13 BTIG $14 $18 +4 +88.1% $9.57
2026-05-13 Barclays $18 $20 +2 +109.0% $9.57
2026-03-18 Truist Financial Srikripa Devarakonda $11 $10 -1 -8.8% $10.96
2026-02-24 Wedbush $24 $11 -13 -11.1% $12.37
2025-12-17 Barclays $16 $18 +2 +51.3% $11.90
2025-10-30 BTIG Jeet Mukherjee $10 $14 +4 +46.0% $9.59
2025-10-15 Goldman Sachs Initiated $6 -36.2% $9.41
2025-10-07 Piper Sandler $81 $16 -65 +71.0% $9.36
2025-09-18 BTIG $16 $10 -6 +26.3% $7.92
2025-09-18 Stephens Sudan Loganathan Initiated $14 +80.6% $7.75
2025-09-16 Barclays $70 $16 -54 +109.4% $7.64
2025-06-02 H.C. Wainwright Andrew Fein $87 $24 -63 +227.4% $7.33
2025-05-05 Truist Financial Srikripa Devarakonda Initiated $11 +44.2% $7.63
2025-05-02 BTIG Jeet Mukherjee $69 $16 -53 +107.3% $7.72
2025-03-13 Morgan Stanley $57 $12 -45 +40.4% $8.55
2025-03-12 BMO Capital Etzer Darout Initiated $20 +137.2% $8.43
2025-03-12 Wells Fargo Derek Archila $63 $26 -37 +213.3% $8.30
2024-12-10 BTIG Jeet Mukherjee Initiated $69 +180.6% $24.59
2024-11-19 Leerink Partners Christopher Liu Initiated $62 +148.6% $24.94
2024-10-31 Oppenheimer Matthew Biegler $70 $40 -30 +44.6% $27.66
2024-10-21 Stifel Nicolaus Bradley Canino $72 $63 -9 +132.4% $27.11
2024-05-16 Oppenheimer Matthew Biegler Initiated $70 +118.0% $32.11
2024-04-12 H.C. Wainwright Andrew Fein Initiated $87 +133.5% $37.26
2024-04-11 Stifel Nicolaus Bradley Canino Initiated $72 +85.9% $38.73
2023-12-19 Wells Fargo Derek Archila $49 $63 +14 +66.4% $37.87
2023-10-23 Wedbush Robert Driscoll $98 $24 -74 +61.8% $14.83
2023-01-02 Wells Fargo $98 $49 -49 +43.2% $34.21
2022-12-05 Citigroup Initiated $72 +74.0% $41.39
2022-11-23 Barclays Initiated $70 +72.0% $40.70
2022-11-22 Piper Sandler Edward Tenthoff $125 $81 -44 +99.0% $40.70
2022-11-11 Morgan Stanley Initiated $57 +24.0% $45.98
2022-02-17 Wedbush Robert Driscoll Initiated $98 +42.0% $69.02
2022-02-08 Wells Fargo Derek Archila Initiated $98 +31.2% $74.68
2021-09-08 Bank of America Securities Tazeen Ahmad Initiated $110 +15.7% $95.07
2021-08-04 Piper Sandler Edward Tenthoff Initiated $125 +23.3% $101.40
2021-05-19 UBS Eliana Merle Initiated $123 +92.3% $63.95

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
3
P/E
1
P/B
3
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ARVN receives an overall rating of C. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), P/E (1/5).
Rating Change History
DateFromTo
2026-04-27 C- C
2026-04-01 C C-
2026-02-24 C+ C
2026-01-03 C C+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

12 Grade D
Profitability
20
Balance Sheet
87
Earnings Quality
68
Growth
12
Value
40
Momentum
20
Safety
0
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. ARVN scores highest in Balance Sheet (87/100) and lowest in Safety (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-1.74
Distress Zone
Piotroski F-Score
2/9
Beneish M-Score
-0.22
Possible Manipulator
Ohlson O-Score
-5.34
Bankruptcy prob: 0.5%
Low Risk
Credit Rating
BB
Score: 43.7/100
Trend: Stable
Earnings Quality
OCF/NI: 1.15x
Accruals: 3.6%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ARVN scores -1.74, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ARVN scores 2/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. ARVN's score of -0.22 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ARVN's implied 0.5% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ARVN receives an estimated rating of BB (score: 43.7/100), with a stable trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-2.63x
PEG
0.02x
P/S
6.56x
P/B
1.50x
P/FCF
-2.64x
P/OCF
EV/EBITDA
-0.01x
EV/Revenue
0.02x
EV/EBIT
-0.01x
EV/FCF
-0.01x
Earnings Yield
-32.62%
FCF Yield
-37.87%
Shareholder Yield
13.55%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. ARVN currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.001
NI / EBT
×
Interest Burden
0.936
EBT / EBIT
×
EBIT Margin
-2.642
EBIT / Rev
×
Asset Turnover
0.099
Rev / Assets
×
Equity Multiplier
1.817
Assets / Equity
=
ROE
-44.5%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ARVN's ROE of -44.5% is driven by Asset Turnover (0.099), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$9.09
Median 1Y
$6.35
5th Pctile
$1.78
95th Pctile
$22.58
Ann. Volatility
75.9%
Analyst Target
$14.75
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
John Houston, Ph.D.
Former President and Chief Executive Officer
$706,236 $2,685,840 $6,534,127
Noah Berkowitz, M.D.,
Ph.D. Chief Medical Officer
$552,387 $1,369,852 $3,593,956
Andrew Saik Financial
ancial Officer and Treasurer
$542,063 $1,261,412 $3,362,314
Angela Cacace, Ph.D.
Chief Scientific Officer
$500,763 $1,261,412 $3,300,914
Ian Taylor, Ph.D.
Former President of Research and Development
$152,567 $364,338 $903,389

CEO Pay Ratio

18:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $6,534,127
Avg Employee Cost (SGA/emp): $363,415
Employees: 246

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
246
-42.8% YoY
Revenue / Employee
$1,067,480
Rev: $262,600,000
Profit / Employee
$-328,455
NI: $-80,800,000
SGA / Employee
$363,415
Avg labor cost proxy
R&D / Employee
$1,150,000
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -37.7% -41.4% -26.8% -30.0% -32.8% -35.5% -42.0% -44.7% -44.2% -43.9% -60.0% -57.9% -52.8% -50.4% -32.6% -7.6% -11.9% -9.6% -16.2% -44.5% -44.46%
ROA -32.1% -35.3% -16.6% -18.6% -20.3% -22.0% -19.8% -21.1% -20.9% -20.7% -28.5% -27.6% -25.1% -24.0% -16.6% -3.9% -6.1% -4.9% -8.9% -24.5% -24.46%
ROIC 3.1% 3.4% 21.6% 23.3% 24.9% 26.7% 32.7% 36.5% 37.6% 38.8% 53.1% 52.5% 49.0% 47.2% 42.3% 16.1% 20.0% 17.2% 37.6% 81.2% 81.18%
ROCE -24.8% -27.3% -14.7% -15.8% -16.7% -17.8% -25.8% -28.3% -28.4% -28.7% -35.9% -36.1% -34.5% -34.1% -29.1% -11.1% -13.8% -10.8% -17.7% -41.0% -41.05%
Gross Margin 1.0% 1.0% 94.1% 92.1% 94.4% 93.7% 94.5% 94.8% 97.1% 95.1% 1.0% 93.3% 97.8% 1.0% 1.0% 1.0% 1.0% 1.0% 87.4% 92.9% 92.95%
Operating Margin -9.4% -5.1% -2.1% -2.2% -1.9% -1.9% -2.0% -2.7% -1.4% -2.1% 3.8% -3.3% -63.4% -58.9% -98.3% 37.8% -3.2% -1.0% -7.5% -4.0% -4.02%
Net Margin -9.1% -5.0% -2.0% -2.4% -2.1% -2.0% -2.2% -2.5% -1.2% -1.8% 3.6% -2.7% -46.0% -48.0% -76.2% 43.9% -2.7% -83.8% -7.1% -3.7% -3.69%
EBITDA Margin -9.2% -5.0% -2.0% -2.1% -1.8% -1.8% -1.8% -2.4% -1.2% -1.8% 3.8% -3.2% -61.2% -57.8% -95.6% 38.5% -3.1% -81.1% -6.9% -3.9% -3.95%
FCF Margin -6.8% 24.9% 11.9% 7.9% 5.2% -2.1% -2.1% -2.3% -2.0% -2.1% -4.5% -5.0% -2.3% -1.6% -99.1% -59.2% -1.1% -1.1% -1.0% -2.9% -2.87%
OCF Margin -6.6% 25.1% 12.0% 8.0% 5.3% -2.0% -2.1% -2.2% -2.0% -2.1% -4.4% -5.0% -2.3% -1.6% -98.4% -58.7% -1.1% -1.0% -1.0% -2.8% -2.84%
ROE 3Y Avg snapshot only -37.69%
ROE 5Y Avg snapshot only -38.73%
ROA 3Y Avg snapshot only -20.76%
ROIC Economic snapshot only -44.77%
Cash ROA snapshot only -35.39%
NOPAT Margin snapshot only -2.21%
Pretax Margin snapshot only -2.47%
R&D / Revenue snapshot only 2.85%
SGA / Revenue snapshot only 96.76%
SBC / Revenue snapshot only 21.03%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -23.01 -22.78 -22.69 -16.71 -9.60 -9.37 -6.44 -4.84 -4.45 -3.60 -6.85 -8.34 -5.92 -5.75 -6.95 -10.95 -7.40 -10.62 -9.53 -3.07 -2.629
P/S Ratio 180.90 181.75 93.07 52.76 23.35 19.76 13.84 10.59 8.38 6.66 32.04 41.51 20.51 11.02 5.25 1.20 1.44 1.99 2.93 7.59 6.560
P/B Ratio 5.86 6.37 5.55 4.56 2.86 3.03 3.22 2.58 2.35 1.88 3.81 4.48 2.90 2.69 2.46 0.91 0.96 1.11 1.77 1.56 1.504
P/FCF -26.41 7.29 7.82 6.66 4.45 -9.64 -6.49 -4.65 -4.11 -3.13 -7.17 -8.31 -8.82 -6.83 -5.29 -2.02 -1.35 -1.89 -2.79 -2.64 -2.641
P/OCF 7.23 7.75 6.59 4.39
EV/EBITDA -19.10 -19.18 -15.05 -10.21 -3.46 -3.83 -2.56 -0.96 -0.47 0.50 -3.40 -4.58 -1.85 -1.48 -1.44 5.78 4.35 4.64 -0.95 -0.01 -0.006
EV/Revenue 148.01 151.35 60.93 30.61 7.73 7.26 4.72 1.86 0.79 -0.86 16.01 23.87 7.03 3.22 1.34 -1.22 -1.32 -1.31 0.35 0.02 0.017
EV/EBIT -18.57 -18.68 -14.65 -9.92 -3.36 -3.70 -2.47 -0.93 -0.45 0.49 -3.34 -4.50 -1.82 -1.45 -1.41 5.43 4.15 4.39 -0.91 -0.01 -0.006
EV/FCF -21.61 6.07 5.12 3.86 1.47 -3.54 -2.21 -0.82 -0.39 0.40 -3.58 -4.78 -3.02 -1.99 -1.35 2.05 1.23 1.24 -0.34 -0.01 -0.006
Earnings Yield -4.3% -4.4% -4.4% -6.0% -10.4% -10.7% -15.5% -20.7% -22.5% -27.8% -14.6% -12.0% -16.9% -17.4% -14.4% -9.1% -13.5% -9.4% -10.5% -32.6% -32.62%
FCF Yield -3.8% 13.7% 12.8% 15.0% 22.5% -10.4% -15.4% -21.5% -24.3% -32.0% -13.9% -12.0% -11.3% -14.6% -18.9% -49.5% -74.3% -53.1% -35.8% -37.9% -37.87%
PEG Ratio snapshot only 0.022
Price/Tangible Book snapshot only 1.563
EV/Gross Profit snapshot only 0.017
Shareholder Yield snapshot only 13.55%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 14.29 14.29 5.93 5.93 5.93 5.93 4.20 4.20 4.20 4.20 4.98 4.98 4.98 4.98 4.64 4.64 4.64 4.64 4.92 4.92 4.917
Quick Ratio 14.29 14.29 5.93 5.93 5.93 5.93 4.20 4.20 4.20 4.20 4.98 4.98 4.98 4.98 4.64 4.64 4.64 4.64 4.92 4.92 4.917
Debt/Equity 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.02 0.02 0.02 0.02 0.02 0.02 0.020
Net Debt/Equity -1.07 -1.07 -1.92 -1.92 -1.92 -1.92 -2.12 -2.12 -2.12 -2.12 -1.91 -1.91 -1.91 -1.91 -1.83 -1.83 -1.83 -1.83 -1.56 -1.56 -1.560
Debt/Assets 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.012
Debt/EBITDA -0.03 -0.02 -0.03 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.04 -0.11 -0.09 -0.11 -0.09 -0.04 -0.037
Net Debt/EBITDA 4.24 3.85 7.94 7.39 6.99 6.60 4.94 4.48 4.45 4.40 3.41 3.39 3.55 3.58 4.22 11.45 9.10 11.70 6.95 2.92 2.921
Interest Coverage -2917.52 -3742.16 -1937.83 -2491.73 -2920.76 -3476.78
Equity Multiplier 1.12 1.12 2.02 2.02 2.02 2.02 2.25 2.25 2.25 2.25 1.98 1.98 1.98 1.98 1.94 1.94 1.94 1.94 1.65 1.65 1.655
Cash Ratio snapshot only 4.810
Cash to Debt snapshot only 80.635
FCF to Debt snapshot only -30.224
Defensive Interval snapshot only 749.7 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.04 0.04 0.04 0.06 0.08 0.10 0.09 0.10 0.11 0.11 0.06 0.06 0.07 0.13 0.22 0.36 0.31 0.26 0.29 0.10 0.099
Inventory Turnover
Receivables Turnover 5.72 6.19 5.83 8.45 11.99 14.97 16.44 17.19 19.77 19.95 19.15 17.39 22.76 39.29 40.84 66.19 57.80 48.42 78.39 26.69 26.687
Payables Turnover 0.00 0.00 0.08 0.19 0.29 0.40 0.44 0.42 0.41 0.38 0.57 0.57 0.58 0.43 0.22 0.11 0.00 0.00 0.06 0.12 0.122
DSO 64 59 63 43 30 24 22 21 18 18 19 21 16 9 9 6 6 8 5 14 13.7 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 4502 1916 1261 915 823 866 900 951 640 640 631 841 1675 3349 5718 2983 2983.5 days
Cash Conversion Cycle -4439 -1873 -1231 -891 -801 -844 -882 -933 -621 -619 -615 -832 -1666 -3344 -5714 -2970 -2969.8 days
Fixed Asset Turnover snapshot only 6.672
Cash Velocity snapshot only 0.130
Capital Intensity snapshot only 8.030
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue -55.6% -8.0% 1.1% 2.2% 3.6% 4.3% 1.8% 1.0% 65.0% 33.2% -40.3% -48.1% -41.0% 0.9% 2.4% 5.0% 3.0% 93.9% -0.3% -79.1% -79.06%
Net Income -91.0% -81.8% -60.1% -54.0% -42.5% -40.6% -47.8% -41.0% -27.6% -16.9% -30.0% -17.9% -8.7% -4.5% 45.8% 86.9% 77.6% 81.0% 59.4% -3.7% -3.75%
EPS -51.3% -42.6% -26.7% -41.3% -31.0% -31.6% -46.7% -40.2% -27.1% -15.0% -13.2% 12.4% 19.3% 21.6% 54.1% 87.0% 77.9% 81.3% 54.9% -4.4% -4.39%
FCF -1.4% 7.7% 6.8% 5.5% 4.5% -1.4% -1.5% -1.6% -1.6% -38.3% -25.1% -13.6% 32.7% 23.5% 25.5% 29.0% -83.8% -26.8% -5.6% -1.6% -1.62%
EBITDA -95.1% -86.4% -63.8% -50.2% -32.8% -27.8% -28.6% -32.1% -25.9% -20.1% -52.2% -38.7% -31.4% -28.8% 33.9% 75.8% 68.0% 74.9% 60.1% -1.6% -1.58%
Op. Income -1.5% -76.3% -56.4% -47.6% -33.6% -31.5% -34.8% -38.8% -34.1% -28.7% -52.5% -35.4% -22.8% -14.7% 37.7% 75.9% 68.0% 71.4% 53.8% -1.6% -1.61%
OCF Growth snapshot only -1.36%
Asset Growth snapshot only -34.22%
Equity Growth snapshot only -22.75%
Debt Growth snapshot only -12.37%
Shares Change snapshot only -11.97%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 88.3% 89.8% 84.1% 86.2% 42.4% 45.2% 44.9% 49.9% 86.8% 53.3% 50.2% 64.9% 92.7% 78.1% 84.8% 57.2% 37.6% 25.9% -13.4% -13.37%
Revenue 5Y 1.2% 63.0% 45.8% 44.4% 31.1% 43.7% 56.7% 51.4% 66.4% 64.5% 33.5% 33.53%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y 88.3% 87.7% 80.7% 82.6% 39.3% 42.1% 42.1% 47.5% 84.0% 48.8% 45.3% 60.8% 90.6% 79.4% 88.0% 60.4% 40.7% 28.5% -12.4% -12.43%
Gross Profit 5Y 1.1% 60.1% 42.9% 42.3% 30.3% 43.3% 56.6% 51.4% 66.4% 64.3% 32.8% 32.83%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 1.2% 99.5% 99.5% 99.5% 99.5% 61.4% 61.4% 61.4% 61.4% 22.1% 22.1% 22.1% 22.1% -11.6% -11.6% -11.6% -11.6% -17.3% -17.3% -17.29%
Assets 5Y 80.2% 45.6% 45.6% 45.6% 45.6% 29.3% 29.3% 29.3% 29.3% 0.0% 0.0% 0.01%
Equity 3Y 12.8% 78.8% 78.8% 78.8% 78.8% 35.6% 35.6% 35.6% 35.6% 0.9% 0.9% 0.9% 0.9% -10.4% -10.4% -10.4% -10.4% -8.4% -8.4% -8.42%
Book Value 3Y 10.9% 49.9% 50.1% 50.1% 52.1% 20.5% 21.7% 21.8% 21.6% -11.1% -11.4% -11.3% -10.8% -19.3% -19.4% -19.4% -19.4% -14.3% -13.8% -13.84%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.03 0.11 0.46 0.55 0.58 0.43 0.60 0.69 0.76 0.78 0.63 0.56 0.60 0.75 0.59 0.51 0.58 0.88 0.79 0.20 0.201
Earnings Stability 0.92 0.97 0.98 0.97 0.96 0.98 0.97 0.98 0.98 0.99 0.98 0.99 0.98 0.96 0.54 0.06 0.06 0.01 0.00 0.00 0.000
Margin Stability 1.00 1.00 0.98 0.97 0.97 0.97 0.97 0.97 0.97 0.97 0.96 0.96 0.96 0.97 0.96 0.96 0.96 0.97 0.96 0.96 0.959
Rev. Growth Consistency 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 0.00 0.00 0.00 1.00 0.50 0.50 0.50 1.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.50 0.50 0.50 0.83 0.84 0.81 0.84 0.89 0.93 0.88 0.93 0.97 0.98 0.82 0.50 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness
ROE Trend 0.16 0.18 0.00 0.01 0.02 0.03 -0.28 -0.29 -0.25 -0.22 -0.18 -0.13 -0.08 -0.04 0.17 0.45 0.38 0.39 0.27 -0.20 -0.200
Gross Margin Trend 0.00 0.00 -0.03 -0.05 -0.06 -0.06 -0.05 -0.03 -0.02 -0.01 -0.04 -0.04 -0.02 0.02 0.06 0.07 0.06 0.04 0.04 0.02 0.023
FCF Margin Trend -4.39 27.14 14.65 11.30 9.30 -12.81 -5.88 -3.44 -1.24 -13.57 -9.35 -7.81 -3.93 0.48 2.31 3.04 1.11 0.82 1.68 -0.08 -0.081
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.84 -3.15 -2.93 -2.54 -2.19 0.94 0.97 1.02 1.07 1.14 0.95 1.00 0.67 0.84 1.30 5.38 5.46 5.60 3.39 1.15 1.148
FCF/OCF 1.03 0.99 0.99 0.99 0.99 1.03 1.02 1.02 1.02 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.011
FCF/Net Income snapshot only 1.161
CapEx/Revenue 22.9% 20.9% 10.2% 8.6% 7.0% 6.3% 5.2% 4.2% 3.2% 2.4% 3.7% 2.7% 2.1% 1.0% 0.7% 0.5% 0.7% 0.6% 0.7% 3.1% 3.13%
CapEx/Depreciation snapshot only 0.622
Accruals Ratio -0.05 -1.46 -0.65 -0.66 -0.65 -0.01 -0.01 0.00 0.01 0.03 -0.02 -0.00 -0.08 -0.04 0.05 0.17 0.27 0.22 0.21 0.04 0.036
Sloan Accruals snapshot only -0.314
Cash Flow Adequacy snapshot only -90.750
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0%
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 2.9% 11.9% 13.5% 13.55%
Net Buyback Yield -13.1% -18.6% -6.1% -7.5% -12.0% -0.2% -0.3% -0.3% -0.3% -3.8% -15.5% -13.2% -20.5% -20.0% -0.4% -0.7% -0.1% 2.8% 11.8% 13.4% 13.44%
Total Shareholder Return -13.1% -18.6% -6.1% -7.5% -12.0% -0.2% -0.3% -0.3% -0.3% -3.8% -15.5% -13.2% -20.5% -20.0% -0.4% -0.7% -0.1% 2.8% 11.8% 13.4% 13.44%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.02 1.04 1.04 1.08 1.06 1.04 1.04 1.00 1.00 1.01 1.01 1.00 1.01 1.00 1.00 1.00 1.00 1.001
Interest Burden (EBT/EBIT) 0.99 0.98 0.99 1.00 1.02 1.03 1.04 1.03 1.03 1.02 0.97 0.93 0.89 0.86 0.79 0.48 0.61 0.63 0.79 0.94 0.936
EBIT Margin -7.97 -8.10 -4.16 -3.09 -2.30 -1.96 -1.91 -2.00 -1.75 -1.75 -4.79 -5.30 -3.87 -2.22 -0.95 -0.22 -0.32 -0.30 -0.39 -2.64 -2.642
Asset Turnover 0.04 0.04 0.04 0.06 0.08 0.10 0.09 0.10 0.11 0.11 0.06 0.06 0.07 0.13 0.22 0.36 0.31 0.26 0.29 0.10 0.099
Equity Multiplier 1.17 1.17 1.61 1.61 1.61 1.61 2.12 2.12 2.12 2.12 2.10 2.10 2.10 2.10 1.96 1.96 1.96 1.96 1.82 1.82 1.817
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-3.35 $-3.61 $-3.62 $-4.03 $-4.38 $-4.75 $-5.31 $-5.65 $-5.57 $-5.46 $-6.01 $-4.95 $-4.50 $-4.28 $-2.76 $-0.64 $-0.99 $-0.80 $-1.24 $-3.46 $-3.46
Book Value/Share $13.13 $12.90 $14.80 $14.75 $14.69 $14.69 $10.62 $10.60 $10.58 $10.44 $10.80 $9.21 $9.18 $9.15 $7.79 $7.73 $7.69 $7.71 $6.69 $6.78 $6.04
Tangible Book/Share $13.13 $12.90 $14.80 $14.75 $14.69 $14.69 $10.62 $10.60 $10.58 $10.44 $10.80 $9.21 $9.18 $9.15 $7.79 $7.73 $7.69 $7.71 $6.69 $6.78 $6.78
Revenue/Share $0.43 $0.45 $0.88 $1.28 $1.80 $2.25 $2.47 $2.58 $2.96 $2.95 $1.28 $0.99 $1.30 $2.23 $3.65 $5.87 $5.11 $4.28 $4.05 $1.40 $1.40
FCF/Share $-2.92 $11.27 $10.50 $10.10 $9.46 $-4.62 $-5.27 $-5.88 $-6.04 $-6.28 $-5.74 $-4.97 $-3.02 $-3.60 $-3.62 $-3.48 $-5.47 $-4.52 $-4.25 $-4.01 $-4.01
OCF/Share $-2.82 $11.37 $10.59 $10.21 $9.59 $-4.47 $-5.14 $-5.77 $-5.95 $-6.21 $-5.69 $-4.94 $-2.99 $-3.58 $-3.60 $-3.45 $-5.43 $-4.49 $-4.22 $-3.97 $-3.97
Cash/Share $14.08 $13.83 $28.46 $28.35 $28.24 $28.24 $22.66 $22.61 $22.57 $22.28 $20.64 $17.59 $17.54 $17.49 $14.42 $14.30 $14.24 $14.26 $10.56 $10.71 $9.61
EBITDA/Share $-3.30 $-3.57 $-3.57 $-3.82 $-4.02 $-4.27 $-4.56 $-5.02 $-5.05 $-5.04 $-6.04 $-5.18 $-4.93 $-4.87 $-3.39 $-1.24 $-1.55 $-1.21 $-1.50 $-3.62 $-3.62
Debt/Share $0.08 $0.08 $0.09 $0.09 $0.09 $0.09 $0.10 $0.10 $0.10 $0.10 $0.05 $0.04 $0.04 $0.04 $0.13 $0.13 $0.13 $0.13 $0.13 $0.13 $0.13
Net Debt/Share $-14.00 $-13.74 $-28.36 $-28.26 $-28.15 $-28.15 $-22.55 $-22.51 $-22.47 $-22.18 $-20.59 $-17.54 $-17.49 $-17.45 $-14.28 $-14.16 $-14.11 $-14.12 $-10.43 $-10.58 $-10.58
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score -1.739
Altman Z-Prime snapshot only -1.924
Piotroski F-Score 3 4 5 5 5 4 3 2 2 2 3 3 4 4 2 3 3 2 4 2 2
Beneish M-Score -2.66 -7.34 4.67 -1.30 -0.21 -0.03 -2.81 -3.01 -2.61 -3.02 -2.59 -2.84 -1.63 3.49 2.90 1.46 -0.95 -0.22 -0.223
Ohlson O-Score snapshot only -5.338
ROIC (Greenblatt) snapshot only -41.32%
Net-Net WC snapshot only $6.51
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BB
Credit Score 60.96 70.95 65.30 58.12 49.49 42.19 49.48 49.39 49.20 49.67 49.69 54.33 49.51 49.78 49.60 44.42 44.36 44.33 44.03 43.66 43.664
Credit Grade snapshot only 12
Credit Trend snapshot only -0.752
Implied Spread (bps) snapshot only 475.000
Industry Credit Rank snapshot only 39
Sector Credit Rank snapshot only 36

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms